An additional mechanism, requiring the TGF-β/SMAD pathway, involves miR-142-3p, which has been shown to attenuate the hyperglycemia-induced EndMT in human aortic endothelial cells (HAECs) (Zhu et al., 2018). Here, TGFB1 is linked to Hyperglycemia.